Literature DB >> 10789535

Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study.

P Boyce1, J Gilchrist, N J Talley, D Rose.   

Abstract

OBJECTIVE: The irritable bowel syndrome (IBS) is a chronic and often disabling functional bowel disorder. Psychological treatments, in particular cognitive and behavioural interventions, have been shown to be effective for this disorder. The aim of this study was to test the efficacy of a cognitive-behaviour program.
METHOD: Eight participants (seven female, one male) aged between 24 and 71 years, with a diagnosis of IBS according to the Rome criteria, were recruited from among the gastroenterology outpatients at Nepean Hospital, in Sydney, Australia. Participants were administered pretreatment on measures of psychological function and bowel symptom severity. Following a 2-week baseline period, participants began a structured psychological treatment comprising eight sessions of cognitive-behaviour therapy. Throughout treatment, participants maintained daily records of symptom severity and completed homework assignments to ensure treatment compliance. The pretreatment assessment measures were repeated 1 week post-treatment.
RESULTS: After treatment, five of the eight patients no longer met the Rome diagnostic criteria for IBS. There was no significant reduction in bowel symptom frequency. There were, however, significant improvements in the distress and disability associated with bowel symptoms. Anxiety and depression were also significantly reduced.
CONCLUSIONS: Cognitive-behaviour therapy reduced the distress and disability associated with IBS, but not the frequency of bowel symptoms. This supports the proposed cognitive model for IBS, and cognitive-behaviour therapy appears to have its effect by altering the cognitive response to visceral hypersensitivity.

Entities:  

Mesh:

Year:  2000        PMID: 10789535     DOI: 10.1080/j.1440-1614.2000.00731.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  17 in total

Review 1.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

2.  High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.

Authors:  Jee-Yon Lee; Stephanie A Cevallos; Mariana X Byndloss; Connor R Tiffany; Erin E Olsan; Brian P Butler; Briana M Young; Andrew W L Rogers; Henry Nguyen; Kyongchol Kim; Sang-Woon Choi; Eunsoo Bae; Je Hee Lee; Ui-Gi Min; Duk-Chul Lee; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2020-07-14       Impact factor: 21.023

3.  Psychologic Therapies for Irritable Bowel Syndrome.

Authors:  Philip Boyce
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

4.  Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire.

Authors:  Rolf Leibbrand; Ulrich Cuntz; Wolfgang Hiller
Journal:  Int J Behav Med       Date:  2002

5.  Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions.

Authors:  Monica E Jarrett; Kevin C Cain; Robert L Burr; Vicky L Hertig; Sheldon N Rosen; Margaret M Heitkemper
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

6.  Abuse, dissociation, and somatization in irritable bowel syndrome: towards an explanatory model.

Authors:  Peter Salmon; Katherine Skaife; Jonathan Rhodes
Journal:  J Behav Med       Date:  2003-02

7.  How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial.

Authors:  Jeffrey M Lackner; James Jaccard; Susan S Krasner; Leonard A Katz; Gregory D Gudleski; Edward B Blanchard
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

Review 8.  Aspects of the non-pharmacological treatment of irritable bowel syndrome.

Authors:  Elsa Maria Eriksson; Kristina Ingrid Andrén; Göran Karl Kurlberg; Henry Ture Eriksson
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

9.  Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.

Authors:  Nicholas J Talley; John E Kellow; Philip Boyce; Christopher Tennant; Sandy Huskic; Michael Jones
Journal:  Dig Dis Sci       Date:  2007-05-15       Impact factor: 3.199

Review 10.  Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Authors:  Qing-Lin Tang; Guo-Yao Lin; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.